126sek
-3,1 %
Date:2026-03-09Time:18:00:00Latest report:Q4-2025List:SpotlightTicker:RESP
Market Cap:10 msekEnterprise Value:3 msekNet Sales:- msekEarnings:-6,95 msekEmployees:0ISIN:SE0023314315

Ratios

10-year key figure history for Respiratorius turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Respiratorius with index and moving average MA50 and MA200.

Stockprice:1,26
MA50:1,52
MA200:3,63
Price/MA200:-65,3 %
RSI (14):40,3
Price/MA50:-17,2 %

Description

Respiratorius is a research company focused on the development of drug candidates for the treatment of cancer, and especially aggressive lymphoma. The company was established in 1999 as a spin-off from Lund University. The operations are located in Sweden, where research is conducted in-house, but also through international partners. The company has its headquarters in Lund.

Biotechnology